Product Detail


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 1269440-69-8, tert-butyl 5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

  • 1269440-69-8

  • C17H24BClFNO4

  • 371.6

  • 1.18±0.1

  • Anticancer

  • Encorafenib

  • 8/5/2033 (Encorafenib)

  • BRAF



Encorafenib, a potent BRAF inhibitor, has demonstrated remarkable efficacy in treating patients with advanced melanoma harboring BRAF mutations. Our meticulously crafted intermediates ensure a seamless manufacturing process, enabling the timely production and supply of this life-saving medication. Join forces with us to revolutionize cancer care, providing patients with renewed hope and improved outcomes. Together, let's pave the way for a brighter future with Encorafenib.